Regenxbio (RGNX) Stock Price, Quote, News & History | Benzinga

Regenxbio Inc (RGNX) Stock Price, Quote, News & History

RGNXNASDAQ

Trade with Public

Trade with Public

$6.84

0.182.70%

Last update: Jun 15, 11:16 AM

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$6.79

Close

-

Volume / Avg.

376.44K / 1.21M

Day Range

$6.77 - $6.95

52 Wk Range

5.46 - 16.19

Market Cap

$353.61M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

17.23%

Days to Cover

4.5

Recent Regenxbio Inc News

REGENXBIO Advances Duchenne Gene Therapy Toward Accelerated Approval

REGENXBIO reports positive Phase 3 Duchenne trial data as RGX-202 met its primary endpoint with strong safety results.

Vandana Singh

Nancy Pelosi Stock Tracker Highlights Claude's Pharma Earnings Play: 'Will Be Interesting To See How This One Plays Out'

Nancy Pelosi Stock Tracker highlighted Claude AI's Denali Therapeutics earnings bet, which targets upside from its rare-disease drug launch.

Ananya Gairola

FDA Clears Denali Therapeutics Drug As First Brain-Penetrating Biologic For Rare Disease

Denali Therapeutic snags FDA accelerated approval for Avlayah for Hunter syndrome, analyst flags strong launch potential.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-233.78M

Investing Cash Flow (TTM)

9.98M

Financing Cash Flow (TTM)

108.93M

Free Cash Flow (TTM)

-236.40M

Capital Expenditure (TTM)

-2.63M

Net Change in Cash (TTM)

-114.88M

Analyst Trends and Forecast

3

1

Feb

2

Mar

2

May

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$265.14M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.93

PB Ratio (TTM)

16.34

Earnings Yield % (TTM)

-84.02%

Earnings Yield % (FWD)

-41.71%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.41

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$15.23M

Debt to Equity

3.37

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$6.79

Close

-

Volume / Avg.

376.44K / 1.21M

Day Range

$6.77 - $6.95

52 Wk Range

5.46 - 16.19

Market Cap

$353.61M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

17.23%

Days to Cover

4.5

About

Sector

Health Care

Industry

Biotechnology

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Regenxbio (RGNX) stock?

A

You can purchase shares of Regenxbio (NASDAQ:RGNX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Regenxbio (RGNX) competitors?

A

There are no as such competitors for Regenxbio.

Q

What is the forecast, or price target, for Regenxbio (RGNX) stock?

A

Regenxbio has a consensus price target of $27.14.

Q

What is the current price for Regenxbio (RGNX)?

A

The stock price for Regenxbio (NASDAQ: RGNX) is $6.84 last updated June 15, 2026 at 11:16 AM EDT.

Q

Does Regenxbio (RGNX) pay a dividend?

A

There are no upcoming dividends for Regenxbio.

Q

When is Regenxbio (NASDAQ:RGNX) reporting earnings?

A

Regenxbio does not have any upcoming earnings scheduled.

Q

Is Regenxbio (RGNX) going to split?

A

There is no upcoming split for Regenxbio.

Q

What sector and industry does Regenxbio (RGNX) operate in?

A

Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.